Health Care/Hospital

Jiangsu Recbio Technology Co., Ltd. announced 2023 annual results report and latest progress

TAIZHOU, China, March 21, 2024 /PRNewswire/ -- Innovative vaccine company Recbio (02179.HK) announced its latest progress and annual results for 2023. The company always adhered to the mission of " Protect Human Health With Best-In-Class Vaccines", and achieved the following milestones and progre...

2024-03-21 00:22 2715

Ubie Launches Checkup Platform for Patient Self-Monitoring, Medication Management and Improved Provider Communication

* Patient health management can be difficult due to limited time with doctors during appointments, low health literacy and poor recall of doctor recommendations * Routine patient generated data can ensure patients stay on track, provide a comprehensive view of health, and provide critical inf...

2024-03-20 22:00 1074

Sisram Medical Announces 2023 Annual Results

Revenues of US$359.3M, with the direct sales portion reaching a record high HONG KONG, March 20, 2024 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK; together with its subsidiaries collectively referred to as the "Group"), a global consumer wellness group, featuring a dist...

2024-03-20 21:53 2922

Antengene Initiates Phase II Dose Expansion Study of Claudin 18.2 ADC ATG-022 in China and Australia

SHANGHAI and HONG KONG, March 20, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in he...

2024-03-20 20:30 2005

Antennova Completes First Dosing Cohort for Anti-CD24 mAb, ATN-031, in the Phase I PERFORM Study

* ATN-031 (also known as ATG-031), is the first anti-CD24 antibody to advance to the clinic in oncology inthe United States * The Phase I PERFORM trial, ongoing at four major U.S. cancer centers, is evaluating the safety and preliminary efficacy of ATN-031 in patients with advanced solid tumor...

2024-03-20 20:30 2073

Innovent Announces 2023 Annual Results and Business Updates

A transformative year of strong performance and material innovation progress ROCKVILLE, M.D. and SUZHOU, China, March 20, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality med...

2024-03-20 19:44 2875

Johnson Matthey signs agreement to sell its Medical Device Components business for US$700m

Johnson Matthey Plc This announcement contains inside information LONDON, March 20, 2024 /PRNewswire/ -- Johnson Matthey Plc (JM) announces that it has signed a definitive agreement to sell 100% of its Medical Device Components business (MDC) to Montagu Private Equity (Montagu) for cash consider...

2024-03-20 19:10 1948

Ultimate Japanese Anti-Aging Technology Comes To Hong Kong - SAISEICO Launches Nobel Prize Winning Japanese Exosome Skincare at Vegas 360 Spas.

HONG KONG, March 20, 2024 /PRNewswire/ -- Japanese Skincare Technology brand SAISEICO will be unveiling its trailblazing new EXCELLENE line of products at a special event in partnership with Vegas 360 spas who will be the first to stock this game changing skincare treatment line at its 18 luxury ...

2024-03-20 18:08 1325

So-Young Reports Unaudited Fourth Quarter and Fiscal Year 2023 Financial Results

BEIJING, March 20, 2024 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the largest and most vibrant social community inChina for consumers, professionals and service providers in the medical aesthetics industry, today announced its unaudited financial resu...

2024-03-20 17:30 1748

STAAR Surgical Celebrates Three Million Implantable Collamer® Lenses

LAKE FOREST, Calif., March 20, 2024 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of the EVO family of Implantable Collamer® Lenses (EVO ICL™) for myopia, astigmatism and presbyopia, today announced that more than three million ICLs have bee...

2024-03-20 16:22 1612

AXA upgrades "SmartTraveller Plus"

Market-leading overseas virtual medical consultation service Providing worry-free travel experience for our customers HONG KONG, March 20, 2024 /PRNewswire/ -- AXA Hong Kong and Macau (AXA) today announced the upgrade of "SmartTraveller Plus'', with newly-added benefits such as virtual medical c...

2024-03-20 16:02 1540

BGI Group Celebrates 20th Anniversary of Partnerships in Healthcare and Genomics in Thailand

BANGKOK, March 20, 2024 /PRNewswire/ -- This year marks the twentieth anniversary of BGI Group's close relationship with the Kingdom ofThailand. Initially both parties were brought together through an international humanitarian rescue effort during the Indian Ocean tsunami where BGI worked with ...

2024-03-20 12:39 1646

320 World Oral Health Day

Oral health is closely related to our well-being Experts call for " A HAPPY MOUTH IS…A HAPPY BODY" HONG KONG, March 20, 2024 /PRNewswire/ -- According to the latest Global Oral Health Status Report published by the World Health Organization inNovember 2022 , the prevalence of oral diseases is ra...

2024-03-20 12:00 435

Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the Development of Transformational Therapies

Proceeds to Support Advancement of Engrail's Pipeline for Neuropsychiatric and Neurodevelopmental Disorders  SAN DIEGO, March 20, 2024 /PRNewswire/ -- Engrail Therapeutics™ (Engrail) (the Company), a precision neuroscience company focused on the development of transformational therapies to impro...

2024-03-20 11:00 1427

Docquity enables Italian biopharmaceutical company Menarini to double HCP reach and engagement in Malaysia

* A Docquity client since 2021, Menarini Malaysia further engaged the platform to raise awareness among target HCPs on multimodal approaches to post-surgery pain management and recovery * Docquity's Awareness to Advocacy (A2A) Program, backed by its in-depth HCP network insights, droveMenarini...

2024-03-20 10:00 1400

Everest Medicines Announces Singapore Health Sciences Authority Approves NEFEGAN® for the Treatment of Primary IgA Nephropathy in Adult Patients

SHANGHAI, March 20, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, development, manufacturing and commercialization of innovative medicines and vaccines, announced today that the Singapore Health Sciences ...

2024-03-20 09:16 1342

FDI World Dental Federation releases powerful video message unifying voices in celebration of World Oral Health Day

In celebration of World Oral Health Day, FDI World Dental Federation debuts an impactful video message uniting voices from diverse sectors, advocating for collective efforts to improve oral health worldwide. GENEVA, March 20, 2024 /PRNewswire/ -- "A Happy Mouth is a Happy Body," says FDI World D...

2024-03-20 09:00 1119

Antengene Publishes Preclinical Paper on PD-L1/4-1BB Bispecific Antibody ATG-101 in Renowned Oncology Journal Cancer Research

SHANGHAI and HONG KONG, March 20, 2024 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in he...

2024-03-20 08:30 1435

China Jo-Jo Drugstores Regains Compliance with Nasdaq Minimum Bid Price Requirement

HANGZHOU, China, March 19, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider inChina, today announced that it ...

2024-03-20 04:05 1614

Datasea Enters into Manufacturing Agreement to Accelerate Production and Deployment of its Hi-Tech Intelligent Acoustic Products

BEIJING, March 19, 2024 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), a digital technology company incorporated inNevada, dedicated to innovative business in acoustic high tech and 5G-Artificial Intelligence multimodal communication technology inthe United States and C...

2024-03-19 22:00 1071
12345678 ... 802

Week's Top Stories